Mean relative percentage in FVC (L) at 3 months · children with cystic fibrosis
Dornase alfa showed no clear difference in mean relative percentage in FVC (L) at 3 months compared with hypertonic saline (low certainty).
1 finding from 1 review
Mean relative percentage in quality of life score at 3 months · children with cystic fibrosis
Dornase alfa showed no clear difference in mean relative percentage in quality of life score at 3 months compared with hypertonic saline (low certainty).
1 finding from 1 review
Pulmonary exacerbations · children with cystic fibrosis
1 finding from 1 review
Manual removal of the placenta · management of retained placenta
Oxytocin solution may leads to lower manual removal of the placenta compared with saline solution (low certainty).
1 finding from 1 review
Maternal death · management of retained placenta
Oxytocin solution showed no clear difference in maternal mortality compared with saline solution (low certainty).
1 finding from 1 review
Severe PPH (≥ 1000 mL) · management of retained placenta
Oxytocin solution showed no clear difference in severe PPH (≥ 1000 mL) compared with saline solution (moderate certainty).
1 finding from 1 review
Blood transfusion · management of retained placenta
Oxytocin solution showed no clear difference in blood transfusion compared with saline solution (moderate certainty).
1 finding from 1 review
Addition of therapeutic uterotonics · management of retained placenta
Oxytocin solution showed no clear difference in addition of therapeutic uterotonics compared with saline solution (low certainty).
1 finding from 1 review
Need for antibiotics · management of retained placenta
Oxytocin solution showed no clear difference in need for treatment with antibiotics (infection) compared with saline solution (moderate certainty).
1 finding from 1 review
Maternal postpartum anaemia (haemoglobin 24–48 hours postpartum) · management of retained placenta
1 finding from 1 review
Time to recurrence · patients with non‐muscle invasive bladder cancer
Gemcitabine showed no clear difference in time to recurrence (absolute effect size estimates based on… compared with saline (low certainty).
1 finding from 1 review
Time to progression · patients with non‐muscle invasive bladder cancer
Gemcitabine showed no clear difference in time to progression (absolute effect size estimates based on… compared with saline (low certainty).
1 finding from 1 review
Adverse events grade 3 to 5 Range of · patients with non‐muscle invasive bladder cancer
Gemcitabine showed no clear difference in grade III–V adverse events compared with saline (low certainty).
1 finding from 1 review
Time to death from bladder cancer · patients with non‐muscle invasive bladder cancer
It is very uncertain whether gemcitabine changes time to death from bladder cancer(absolute effect size estimates… compared with saline (very low certainty).
1 finding from 1 review
Overall survival (absolute effect size estimates based on survival rate at 12 months) · patients with non‐muscle invasive bladder cancer
It is very uncertain whether gemcitabine changes time to death from any cause (absolute effect size estimates based… compared with saline (very low certainty).
1 finding from 1 review
Adverse events: grade 1 to 2 · patients with non‐muscle invasive bladder cancer
Gemcitabine showed no clear difference in grade I or II adverse events compared with saline (low certainty).
1 finding from 1 review
Disease‐specific quality of life · patients with non‐muscle invasive bladder cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ulcer healing · people with venous leg ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ulcer healing · participants with chronic leg ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of wounds healed · participants with chronic leg ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found